Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression

NCT01282632 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Subjects Had Unipolar, Non-psychotic Major Depression

Interventions

DRUG: Risperidone
DRUG: Olanzapine

Sponsor

Sunnybrook Health Sciences Centre